Akebia Therapeutics Statistics
NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.3855-0.0368 (-8.71%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Akebia Therapeutics by the numbers
Akebia Therapeutics has a market capitalization of $107.0 million based on 277.66M shares outstanding. With trailing EPS of $-0.17, Akebia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 46.1% below its 50-day average and 64.3% below its 200-day average.
Average daily trading volume is 8.05M shares, or about $3.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AKBA valuation vs. peer median
| Metric | AKBA | Peer median | Difference |
|---|---|---|---|
| Market cap | $107.04M | $108.89M | -2% |
| Avg. volume | 8.05M | 334.55K | +2307% |
Peer median across 8 companies: BGM, SPRB, MENS, GNLX, FHTX, IMUX, OKUR, ORGO.
Valuation
- Market cap
- $107.04M
- Price / sales (latest FY)
- 0.45
- EPS (TTM)
- $-0.17
- Shares outstanding
- 277.66M
Price and trading
- Previous close
- 0.4223
- Open
- 0.41
- Day range
- 0.3849 – 0.4331
- 52-week range
- 0.361 – 1.73
- 52-week change
- -75.13%
- 50-day moving average
- 0.7156
- Beta
- —
- Volume
- 4.57M
- Average volume
- 8.05M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 107.04M
- Forward Pe
- -0.84
- Eps
- -0.17
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.73
- Week52 Low
- 0.36
- Avg Volume
- 8.05M
- Shares Outstanding
- 277.66M
- Ma50
- 0.72
- Ma200
- 1.08
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -77.72%
- Pct From52w Low
- 6.79%